Docetaxel Injection is an antineoplastic agent
intended for the treatment of breast cancer, non-small cell lung cancer ("NSCLC"), prostate cancer, gastric adenocarcinoma, and head and neck cancer.
Prevalence of antineoplastic agent
use was estimated from the literature.
Cladribine is an antineoplastic agent
that has been approved for the treatment of active hairy cell leukemia.
We report a case of pulmonary toxicity associated with the relatively new antineoplastic agent
SAN DIEGO -- The antineoplastic agent
letrozole is a promising alternative to clomiphene citrate as a frontline treatment for ovulation induction, results of a small prospective study suggest.
Hycamtin, ovarian cancer, Topotecan, Topoisomerase I inhibitor, recurrent gynecologic malignancies, second line treatment of ovarian cancer, cervical and small cell lung cancer, metastatic ovarian cancer, platinum-sensitive and platinum-resistant, platinum-sensitive patients, antineoplastic agent
, torsional strain, sales forecast, phase III/pipeline, competitors to hycamtin gemcitabine liposomal doxorubicin Avastin paclitaxel carboplatin paclical
SCOPE OF THE PANORAMA medical oncology, radiation oncology, pharmaceutical composition, clinical trial, malignant tumor, pediatric oncology, cancer, radiation therapy, antineoplastic agent
, oncological disease, oncology nursing, gynecologic oncology
Docetaxel is an antineoplastic agent
used to treat a broad spectrum of cancers, including breast cancer, non-small cell lung cancer, stomach cancer and prostate cancer.
A human epidermal growth factor receptor type 1/epidermal growth factor receptor (HER-1/EGFR) tyrosine kinase inhibitor used in combination with the antineoplastic agent
gemcitabine for advanced pancreatic cancer in patients who have not yet received chemotherapy.
Imatinib (Gleevec), an antineoplastic agent
used to treat chronic myeloid leukemia, may help to put type 2 diabetes mellitus in regression, according to Dino Veneri, M.
An antineoplastic agent
for androgen-independent (hormone-refractory) metastatic prostate cancer.
s Closed System for Antineoplastic Agent
Administration," was conducted by a team of nurses at the Abramson Cancer Center of the Hospital of the University of Pennsylvania, a National Cancer Institute-designated comprehensive cancer center with more than 55,000 doses of chemotherapy delivered per year.